Dysbiosis of Oral Microbiota and Metabolite Profiles Associated with Type 2 Diabetes Mellitus

被引:17
|
作者
Li, Yujiao [1 ,2 ,3 ,4 ]
Qian, Fei [1 ,2 ,3 ,4 ,5 ]
Cheng, Xiaogang [1 ,2 ,3 ,4 ]
Wang, Dan [1 ,2 ,3 ,4 ]
Wang, Yirong [1 ,2 ,3 ,4 ]
Pan, Yating [1 ,2 ,3 ,4 ]
Chen, Liyuan [1 ,2 ,3 ,4 ]
Wang, Wei [1 ,2 ,3 ,4 ]
Tian, Yu [1 ,2 ,3 ,4 ]
机构
[1] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Xian, Peoples R China
[2] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Sch Stomatol, Xian, Peoples R China
[3] Fourth Mil Med Univ, Sch Stomatol, Shaanxi Key Lab Stomatol, Xian, Peoples R China
[4] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian, Peoples R China
[5] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian, Peoples R China
来源
MICROBIOLOGY SPECTRUM | 2023年 / 11卷 / 01期
基金
中国国家自然科学基金;
关键词
metagenomic; metabolomic; type 2 diabetes mellitus; oral diseases; oral microbiome; ALIGNMENT; CELL;
D O I
10.1128/spectrum.03796-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The incidence of oral diseases in type 2 diabetic patients might increase, and the severity might also be more serious. At present, the relationship between oral microorganisms and type 2 diabetes mellitus (T2DM) has become a hot topic in systemic health research. Several previous studies have shown that oral microbial disorders may be closely related to the occurrence and development of type 2 diabetes mellitus (T2DM). However, whether the function of oral microorganisms and their metabolites have changed in patients with T2DM who have not suffered from any oral diseases has not been reported. We performed metagenomic analyses and nontargeted metabolic analysis of saliva and supragingival plaque samples from patients with T2DM who have not suffered any oral diseases and normal controls. We found that periodontal pathogens such as Porphyromonas gingivalis and Prevotella melaninogenica were significantly enriched, while the abundances of dental caries pathogens such as Streptococcus mutans and Streptococcus sobrinus were not significantly different in patients with T2DM compared to those in normal controls. Metabolomic analyses showed that the salivary levels of cadaverine and L-(+)-leucine of patients with T2DM were significantly higher than those of normal controls, while the supragingival plaque levels of N-acetyldopamine and 3,4-dimethylbenzoic acid in patients with T2DM were significantly higher than those in the normal controls. Additionally, we identified the types of oral microorganisms related to the changes in the levels of circulating metabolites, and the oral microorganisms were involved in the dysregulation of harmful metabolites such as cadaverine and n, n-dimethylarginine. Overall, our study first described the changes in the composition of oral microorganisms and their metabolites in patients with T2DM who have not suffered any oral diseases, which will provide a direct basis for finding oral biomarkers for early warning of oral diseases in T2DM.IMPORTANCE The incidence of oral diseases in type 2 diabetic patients might increase, and the severity might also be more serious. At present, the relationship between oral microorganisms and type 2 diabetes mellitus (T2DM) has become a hot topic in systemic health research. However, whether the function of oral microorganisms and their metabolites have changed in patients with T2DM who have not suffered from any oral diseases has not been reported. We found that even if the oral condition of T2DM is healthy, their oral microbes and metabolites have changed, thus increasing the risk of periodontal disease. Our study first described the changes in the composition of oral microorganisms and their metabolites in T2DM who have not suffered any oral diseases and revealed the correlation between oral microorganisms and their metabolites, which will provide a direct basis for finding oral biomarkers for early warning of oral diseases in patients with T2DM.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] A systematic review on gut microbiota in type 2 diabetes mellitus
    Chong, Serena
    Lin, Mike
    Chong, Deborah
    Jensen, Slade
    Lau, Namson S.
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [42] Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin
    Huo, Lixia
    Li, Hui
    Zhu, Ming
    Liu, Yang
    Ren, Lingyan
    Hu, Jia
    Wang, Xiaoyi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [43] Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus
    Inzucchi, Silvio E.
    Kosiborod, Mikhail
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (01) : 73 - 74
  • [44] Oral agents in the management of type 2 diabetes mellitus
    Luna, B
    Feinglos, MN
    AMERICAN FAMILY PHYSICIAN, 2001, 63 (09) : 1747 - 1756
  • [45] Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus
    Richard, Thibault
    Brohee, Dany
    Van Meerhaeghe, Alain
    Vanhaeverbeek, Michel
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (01) : 76 - 76
  • [46] Oral antihyperglycaemic agents in type 2 diabetes mellitus
    Smith, Haley
    SA PHARMACEUTICAL JOURNAL, 2014, 81 (03) : 10 - 14
  • [47] Oral antihyperglycemic therapy for type 2 diabetes mellitus
    Cheng, AYY
    Fantus, IG
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (02) : 213 - 226
  • [48] Pyuria Is Associated with Dysbiosis of the Urinary Microbiota in Type 2 Diabetes Patients Receiving Sodium-Glucose Cotransporter 2 Inhibitors
    Lin, Hsueh-Ju
    Chuang, Han-Ni
    Jhan, Pei-Pei
    Ye, Han-Yu
    Lee, I-Te
    Hsiao, Tzu-Hung
    Liu, Po-Yu
    MICROBIOLOGY RESEARCH, 2023, 14 (01) : 34 - 41
  • [49] Metabolite profiling as a future tool in the prediction of type 2 diabetes mellitus
    Karakas, Mahir
    Koenig, Wolfgang
    CLINICAL ENDOCRINOLOGY, 2012, 76 (05) : 615 - 616
  • [50] Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose
    Ruifang Li-Gao
    de Mutsert, Renee
    Rensen, Patrick C. N.
    van Klinken, Jan Bert
    Prehn, Cornelia
    Adamski, Jerzy
    Vlieg, Astrid van Hylckama
    den Heijer, Martin
    le Cessie, Saskia
    Rosendaal, Frits R.
    van Dijk, Ko Willems
    Mook-Kanamori, Dennis O.
    METABOLOMICS, 2018, 14 (01)